Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Dengue Vaccine: The Current Status.

Mustafa MS, Agrawal VK.

Med J Armed Forces India. 2008 Apr;64(2):161-4. doi: 10.1016/S0377-1237(08)80065-2. Epub 2011 Jul 21.

2.

A lethal murine infection model for dengue virus 3 in AG129 mice deficient in type I and II interferon receptors leads to systemic disease.

Sarathy VV, White M, Li L, Gorder SR, Pyles RB, Campbell GA, Milligan GN, Bourne N, Barrett AD.

J Virol. 2015 Jan 15;89(2):1254-66. doi: 10.1128/JVI.01320-14. Epub 2014 Nov 12.

3.

Utility, limitations, and future of non-human primates for dengue research and vaccine development.

Sariol CA, White LJ.

Front Immunol. 2014 Sep 24;5:452. doi: 10.3389/fimmu.2014.00452. eCollection 2014. Review.

4.

Flaviviruses, an expanding threat in public health: focus on dengue, West Nile, and Japanese encephalitis virus.

Daep CA, Muñoz-Jordán JL, Eugenin EA.

J Neurovirol. 2014 Dec;20(6):539-60. doi: 10.1007/s13365-014-0285-z. Epub 2014 Oct 7. Review.

5.

Endothelial cells in dengue hemorrhagic fever.

Srikiatkhachorn A, Kelley JF.

Antiviral Res. 2014 Sep;109:160-70. doi: 10.1016/j.antiviral.2014.07.005. Epub 2014 Jul 12. Review. Erratum in: Antiviral Res. 2015 Feb;114:47.

6.

Viral kinetics of primary dengue virus infection in non-human primates: a systematic review and individual pooled analysis.

Althouse BM, Durbin AP, Hanley KA, Halstead SB, Weaver SC, Cummings DA.

Virology. 2014 Mar;452-453:237-46. doi: 10.1016/j.virol.2014.01.015. Epub 2014 Feb 14. Review.

7.

A chimeric dengue virus vaccine using Japanese encephalitis virus vaccine strain SA14-14-2 as backbone is immunogenic and protective against either parental virus in mice and nonhuman primates.

Li XF, Deng YQ, Yang HQ, Zhao H, Jiang T, Yu XD, Li SH, Ye Q, Zhu SY, Wang HJ, Zhang Y, Ma J, Yu YX, Liu ZY, Li YH, Qin ED, Shi PY, Qin CF.

J Virol. 2013 Dec;87(24):13694-705. doi: 10.1128/JVI.00931-13. Epub 2013 Oct 9.

8.

A novel single-dose dengue subunit vaccine induces memory immune responses.

Chiang CY, Liu SJ, Tsai JP, Li YS, Chen MY, Liu HH, Chong P, Leng CH, Chen HW.

PLoS One. 2011;6(8):e23319. doi: 10.1371/journal.pone.0023319. Epub 2011 Aug 3.

9.

Vaccination with dengue virus-like particles induces humoral and cellular immune responses in mice.

Zhang S, Liang M, Gu W, Li C, Miao F, Wang X, Jin C, Zhang L, Zhang F, Zhang Q, Jiang L, Li M, Li D.

Virol J. 2011 Jun 30;8:333. doi: 10.1186/1743-422X-8-333.

10.

Development of a recombinant tetravalent dengue virus vaccine: immunogenicity and efficacy studies in mice and monkeys.

Clements DE, Coller BA, Lieberman MM, Ogata S, Wang G, Harada KE, Putnak JR, Ivy JM, McDonell M, Bignami GS, Peters ID, Leung J, Weeks-Levy C, Nakano ET, Humphreys T.

Vaccine. 2010 Mar 24;28(15):2705-15. doi: 10.1016/j.vaccine.2010.01.022. Epub 2010 Jan 22.

11.

Two complex, adenovirus-based vaccines that together induce immune responses to all four dengue virus serotypes.

Holman DH, Wang D, Raviprakash K, Raja NU, Luo M, Zhang J, Porter KR, Dong JY.

Clin Vaccine Immunol. 2007 Feb;14(2):182-9. Epub 2006 Dec 27.

13.

Dengue 2 PDK-53 virus as a chimeric carrier for tetravalent dengue vaccine development.

Huang CY, Butrapet S, Tsuchiya KR, Bhamarapravati N, Gubler DJ, Kinney RM.

J Virol. 2003 Nov;77(21):11436-47.

14.
15.

West Nile virus/dengue type 4 virus chimeras that are reduced in neurovirulence and peripheral virulence without loss of immunogenicity or protective efficacy.

Pletnev AG, Putnak R, Speicher J, Wagar EJ, Vaughn DW.

Proc Natl Acad Sci U S A. 2002 Mar 5;99(5):3036-41. Erratum in: Proc Natl Acad Sci U S A 2002 May 14;99(10):7184.

17.

Chimeric dengue type 2 (vaccine strain PDK-53)/dengue type 1 virus as a potential candidate dengue type 1 virus vaccine.

Huang CY, Butrapet S, Pierro DJ, Chang GJ, Hunt AR, Bhamarapravati N, Gubler DJ, Kinney RM.

J Virol. 2000 Apr;74(7):3020-8.

18.
19.

Yellow fever/Japanese encephalitis chimeric viruses: construction and biological properties.

Chambers TJ, Nestorowicz A, Mason PW, Rice CM.

J Virol. 1999 Apr;73(4):3095-101.

Supplemental Content

Support Center